IP Library Granted Patent US 7,002,014
Granted Patent B2
US 7,002,014 · App. 10/901,692 · Granted Feb 21, 2006

Process for controlling crystal structure of risedronate

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,002,014
App. No.
10/901,692
Granted
Feb 21, 2006
Kind
B2
Abstract

The present invention relates to a process for controlling the crystal form of 3-pyridyl-1-hydroxy-ethylidene-1,1-bisphosphonic acid salt (Risedronate). The process employs a pH adjustment step to induce the proper hydrate form and thereby avoiding inadvertent nucleation of undesired hydrate forms.

Claims (49)

1. A process for preparing 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid salt in the hemipentahydrate crystal form, said process comprising the steps of:

a) dissolving in an admixture of isopropyl alcohol and water, 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid and an inorganic base in sufficient amount to provide a pH of 6, to form a solution;

b) heating the solution from about 50° C. to about 60° C. to form a heated solution;

c) filtering said heated solution to form a filtered solution;

d) adjusting the pH of said filtered solution with an inorganic acid to a pH range of from 4.7 to 5 while maintaining the temperature at the level oblained in step (b) to form a neutralized solution;

e) cooling the neutralized solution to a temperature of about 20° C. to about 40° C. to form a nucleating slurry of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid salt;

f) adding to said slurry isopropyl alcohol and sufficient inorganic acid to provide a pH of from 4.7 to 5.2 to form a ripened slurry of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid salt in the hemipentahydrate crystal form; and

g) isolating 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid salt hemipentahydrate.

2. A process according to claim 1 wherein the ratio of isopropyl alcohol to water in step (a) is 1:6.7.

3. A process according to claim 1 wherein rhc ratio of isopropyl alcohol to water in step (a) is from 1:5.9 to 1:9.1.

4. A process according to claim 1 wherein said inorganic base is step (a) is selected from the group consisting of NaOH, NaOCH 3 , and NaOC(O)CH 3 .

5. A process according to claim 4 wherein said inorganic base is NaOH.

6. A process according to claim 1 wherein said temperature in step (b) is from 52° C. to 58° C.

7. A process according to claim 6 wherein said temperature is 55° C.

8. A process according to claim 1 wherein said filtered solution formed in step (c) has the same temperature as the heated solution formed in step (b).

9. A process according to claim 1 wherein said inorganic acid in step (d) is selected from the group consisting of HCl, H 2 SO 4 , and H 3 PO 4 .

10. A process according to claim 9 wherein said inorganic acid is HCl.

11. A process according to claim 1 wherein said temperature in step (e) is from 20° C. to 40° C.

12. A process according to claim 11 wherein said temperature is from 20° C. to 30° C.

13. A process according to claim 12 wherein said temperature is 25° C.

14. A process according to claim 1 wherein said inorganic acid in step (f) is selected from the group consisting of HCl, H 2 SO 4, and H 3 PO 4 .

15. A process according to claim 14 wherein said inorganic acid is HCl.

16. A process according to claim 1 wherein said isopropyl alcohol and inorganic acid used to form said ripened slurry in step (f) is added as an admixture.

17. A process according to claim 1 wherein said isopropyl alcohol added in step (f) is added separately from said and inorganic acid.

18. A process according to claim 17 wherein said isopropyl alcohol and said inorganic acid are added separately but concurrently.

19. A process according to claim 17 wherein said isopropyl alcohol and said inorganic arid are added in alternating portions.

20. A process according to claim 1 wherein said product isolated in step (g) is isolated by filtration.

21. A process according to claim 1 wherein said product isolated in step (g) is isolated by decanting the solvent.

22. A process according to claim 1 wherein said product isolated in step (g) is isolated by centrifugation.

23. A process according to claim 1 having the optional step (c) (i), said step comprising:

c) (i) adding to said filtered solution 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid salt hemipentahydrate seed crystals.

24. A process according to claim 1 wherein said product formed in step (f) is in the platelet crystal form.

25. A process according to claim 1 wherein when said nucleating slurry formed in step (e) comprises an admixture of monahydrate and hemipentahydrate crystal forms, said process having further

c) (i) holding said nucleating slurry to a temperature from about 20° C. to about 30°C. and holding said slurry at said temperature until said monohydrate form is converted to said hemipentahydrate form;

e) (ii) repeating step (e).

26. A process for preparing 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid salt in the hemipentahydrate crystal form, said process comprising the steps of:

a) dissolving in an admixture of isopropyl alcohol and water, 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid and an inorganic base in sufficient amount to provide a pH of 6, to form a solution;

b) heating the solution from about 50° C. to about 60° C. to form a heated solution;

c) filtering said heated solution to form a filtered solution;

d) adjusting the pH of said filtered solution with an inorganic acid to a pH range of from 4.7 to 5 while maintaining the temperature at the level obtained in step (b) to form a neutralized solution;

e) cooling the neutralized solution to a temperature of about 20° C. to about 40° C. to form a nucleating slurry of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid salt; and

f) isolating 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid salt hemipentahydrate.

27. A process for preparing 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid salt in the hemipentahydrate crystal form, said process comprising the steps of:

a) dissolving in an admixture of isopropyl alcohol and water, 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid arid NaOH in sufficient amount to provide a pH of 6, to form a solution;

b) heating the solution to 55° C. to form a heated solution;

c) filtering said heated solution to form a filtered solution, while maintaining a temperature of 55° C.;

d) adjusting the pH of said filtered solution with HCl to a pH range of from 4.7 to 5, while maintaining a temperature of 55° C., to form a neutralized solution;

e) cooling the neutralized solution to 25° C. to form nucleating slurry of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid salt; and

f) adding to said slurry isopropyl alcohol and sufficient HCl to provide a pH of from 4.7 to 5.2 to form a ripened slurry of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid salt in the hemipentahydrate crystal form.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE US PATENT NO. 8,050,873 PREVIOUSLY RECORDED ON REEL 040183 FRAME 0129. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 22, 2018
From: WARNER CHILCOTT COMPANY, LLC
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 045417/0593 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2016
From: WARNER CHILCOTT COMPANY, LLC
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 040183/0129 →
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2013
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 031531/0538 →
RELEASE - REEL 023456, FRAME 0052 Recorded Mar 29, 2011
From: CREDIT SUISSSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
To: WARNER CHILCOTT COMPANY LLC
Reel/Frame 026042/0046 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2010
From: PROCTER & GAMBLE COMPANY, THE
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 023796/0417 →